Merck nears deal to sell consumer healthcare unit, Reuters says Merck (MRK) is near a deal to sell its consumer healthcare unit for close to $14B, says Reuters. A deal for the business may come as soon as next week with Bayer (BAYRY ) and Britian's Reckitt Benckiser Group as top contenders, added Reuters. Reference Link
News For MRK;BAYRY From The Last 14 Days
Check below for free stories on MRK;BAYRY the last two weeks.
FDA approves Belsomra sleep drug The Food and Drug Administration approved Belsomra tablets for use as needed to treat difficulty in falling and staying asleep. Belsomra is an orexin receptor antagonist and is the first approved drug of this type. Belsomra will be dispensed with an FDA-approved patient Medication Guide that provides instructions for its use and important safety information. Belsomra is a controlled substance because it can be abused or lead to dependence. Belsomra is made by Merck, Sharpe & Dohme.